We report a simple, versatile in situ transmission electron microscopy (TEM) approach for investigating the nucleation and growth mechanism of carbon nanotubes (CNTs), by which the composition, phase transition, and physical state of various catalysts can be clearly resolved. In our approach, catalyst nanoparticles (NPs) are placed in a multiwall CNT "tubular furnace" with two open ends, and a high temperature is obtained by Joule heating in the specimen chamber of a TEM. The carbon is supplied by electron irradiation-induced injection of carbon atoms. Comparative studies on the catalytic behavior of traditional iron oxide and recently discovered gold catalysts were performed. It was found that the growth of CNTs from iron oxide involves the reduction of Fe2O3 to Fe3C, nucleation and growth of CNTs from partially liquefied Fe3C, and finally the formation of elemental Fe when the growth stops. In contrast, while changes in shape, size, and orientation were also observed for the fluctuating Au NPs, no chemical reactions or phase transitions occurred during the nucleation of CNTs. These two distinct nucleation and growth processes and mechanisms would be valuable for the structure-controlled growth of CNTs by catalyst design and engineering.

Download full-text PDF

Source
http://dx.doi.org/10.1021/nn403927yDOI Listing

Publication Analysis

Top Keywords

iron oxide
12
nucleation growth
12
growth cnts
12
gold catalysts
8
carbon nanotubes
8
situ transmission
8
transmission electron
8
electron microscopy
8
growth
6
nucleation
5

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

5M Biomed, LLC, Atlanta, GA, USA.

Background: Enriching and detecting Alzheimer's disease (AD) biomarkers in cerebral spinal fluid (CSF) or blood samples are increasingly applied in the AD diagnosis and monitoring of disease progression and treatment response. The accuracy of these processes is dependent on the sensitivity and specificity of capturing and quantifying AD biomarkers, e.g.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

5M Biomed, LLC, Atlanta, GA, USA.

Background: Liquid biopsy for Alzheimer's disease (AD) biomarkers in cerebral spinal fluid (CSF) or blood samples is becoming a significant sector in the management of AD and AD related dementia (ADRD). Whereas different types of molecules, such as small molecules, peptides, and antibodies, have been used as ligands for targeting AD biomarkers/pathologies such as amyloid beta peptides (Aβs), current liquid biopsy approaches mostly use antibodies. However, the activity and affinity of the antibodies can vary depending on the source and preparation as well as the stability in storage.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Daegu Catholic University, Daegu, Daegu Metropolitan City, Korea, Republic of (South).

Background: The interplaying neuropathology of amyloid plaque, tau tangles, and microglia-driven inflammation (tri-pathology) are related to neuronal and synaptic loss damage in Alzheimer's damages. Interventions that target Aβ or tau individually have not yielded substantial breakthroughs. Iron plays a pivotal role in tri-pathology by protein-bound iron-oxide deposition in amyloid plaque, tau tangle, and microglia, resulting in redox-active toxicity or microglial response induction, such as proinflammatory activation, autophagy dysfunction, and ferroptosis.

View Article and Find Full Text PDF

Background: The metal oxide nanoparticles possess unique properties such as biological compatibility, superior reactivity, and capacity to develop reactive oxygen species, due to this they have drawn significant interest in cancer treatment. The various MONPs such as cerium oxide, Copper oxide, Iron oxide, Titanium dioxide, and Zinc oxide have been investigated for several types of cancers including brain, breast, cervical, colon, leukemia, liver, lung, melanoma, ovarian, and prostate cancers. However, traditional physiochemical synthetic methods for MONPs commonly include toxic materials, a major concern that raises questions regarding their biocompatibility and safety.

View Article and Find Full Text PDF

Introduction: Iron oxide nanozyme was synthesized from the fruit peel extract of pomegranate, which served as a reducing agent during the green synthesis. The scavenging of reactive oxygen species is often accompanied by immunomodulation following antiproliferative effects due to the crosstalk between the proteins involved in the inter-related signaling pathways.

Method: In the current study, the green synthesized nanozyme was studied for its ability to induce apoptosis in breast cancer cell lines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!